Celia Keim Patel

Celia Keim Patel has extensive experience in medical writing and regulatory affairs, currently serving as Director of Medical Writing at Eisai US since November 2017, where previous roles included Associate Director and Senior Manager. Prior to Eisai, Celia held the position of Principal Medical Writer at Glenmark Pharmaceuticals from June 2016 to November 2017, contributing significantly to regulatory writing activities, managing teams, and ensuring compliance with regulatory guidelines. Earlier experience includes Medical Writing roles at WCCT Global and Tricore Inc., along with analytical and research positions at The Dedham Group and Columbia University. Celia possesses a Ph.D. in Pathobiology from Columbia University, complemented by a B.S. in Biochemistry and Molecular Biology from The Pennsylvania State University.